MERIDIAN BIOSCIENCE, INC. 410500 Revogene Carba C

Burr, Oval, 10 flute, 3.0mm

GE OEC Elite CFD 31cm Flat Detector Super C-Arm - VAS 15 Software. GE OEC Elite CFD C-Arm 31 cm Flat Detector w/ Bumper VAS 15 Vascular Software, SUPER C Motorized C Refurbished, Calibrated, Ready for Use 31 cm CMOS Flat Detector (CFD) - CMOS - Complementary metal-oxide semiconductor detector - DQE(0): 72% - Active amplification inside pixel for ultra-fast electron mobility - Active Matrix: 1548x1524 pixels - Pixel Pitch: 190.0 um - Nominal resolution (at display): 31 cm: 2.7 lp/mm; 21 cm: 2.8 lp/mm; 15 cm: 2.9 lp/mm - Quad-mode magnification: Live Zoom fluidly from 1 to 4X with no change in dose; Fixed try-mode Mag settings: 31cm/21cm/15cm Workstation Display - 13.6 in Live and Reference Image displayed size - 1 to 1 detail imaging chain from CMOS detector to 4K display resolution - Squircle shaped image retains 100% of image when rotated and no cropped or changed view. - 4K, 32" Ultra high definition (UHD) Color Display - Monitor displays two split screens for equivalent view of two 20in displays - 3840x2160 display resolution - 600 cd/m2 maximum brightness - Touchscreen interface with anti-reflection, anti-fingerprint - Easily position monitor to surgical line of sight with display mount on an articulating arm with five movements What's Included: GE OEC Elite CFD C-Arm, Super C; (REF OEC Elite) Qty: 1 GE Beam Limiting Device; (REF 5455288-03) Qty: 1 GE Laser Aiming Device; (REF 5440087) Qty: 1 GE Image Receptor; (REF 5457729-02) Qty: 1 GE Remote User Interface; (REF 5719003-01) Qty: 1 GE Hand Control OEC ELITE; (REF 5819193); Qty; 1 GE Foot Switch; (REF 1482807); Qty: 1 GE Skin Spacer - Squircular; (REF 5436688-01) Qty: 2

The Stat Profile Prime Plus Blood Analyzer is a compact, whole blood critical care analyzer that provides rapid and comprehensive results. It measures blood gases, electrolytes, metabolites, and co-oximetry, delivering 32 calculated results. Featuring maintenance-free, replaceable cartridge technology and patented non-lysing co-oximetry, the analyzer produces a complete test panel in about one minute. It also offers bidirectional connectivity and a powerful onboard data management system for efficient data handling and integration

The Revogene® Carba C assay, performed on the Revogene® instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The Revogene Carba C assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative Revogene Carba C assay result does not preclude the presence of other resistance mechanisms.The Revogene Carba C assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.

The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The GenePOC Carba assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative GenePOC Carba assay result does not preclude the presence of other resistance mechanisms.The GenePOC Carba assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.